Austedo XR 12 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FBVYE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,643
Award facts
- Contract value 100% obligated
- $12,642.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,642.67 delivery order to AmerisourceBergen Drug Corp for AUSTEDO XR 12 mg tablets (30-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
AUSTEDO XR is a prescription medication used to treat tardive dyskinesia, a neurological movement disorder, making this delivery order part of the company's comprehensive portfolio of neurological and specialty pharmaceutical products supplied to the Defense Health Agency and other federal healthcare systems. The contract demonstrates AmerisourceBergen's ongoing capability to fulfill federal pharmaceutical supply requirements through its established relationships with DLA and its role as a prime vendor in the military medical supply chain. The short completion timeline reflects the time-sensitive nature of pharmaceutical procurement for federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FBVYE?
SPE2DB25FBVYE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2025.
How much is contract SPE2DB25FBVYE worth?
The government has obligated $12,643 on SPE2DB25FBVYE.
Is contract SPE2DB25FBVYE an order under another contract?
Yes. SPE2DB25FBVYE is a delivery order under SPE2DB24D2012, an indefinite delivery contract.
Was contract SPE2DB25FBVYE competed?
The extent of competition for SPE2DB25FBVYE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award